Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scottish imaging spend targets cancer needs

This article was originally published in Clinica

Executive Summary

Scotland says it is on track to meet its cancer mortality reduction targets, for which investments in imaging equipment are playing a key role. According to new data, deaths from lung, colorectal and prostate cancers in men have fallen by 25%, 14% and 9% during the period 1995-2005. Among women, breast and colorectal cancer deaths have fallen by 14% and 24%. Scotland is aiming to reduce overall cancer death rates in under-75s by 20% between 1995 and 2010.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052900

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel